CANY
ICUI icon

Caxton Associates (New York)’s ICU Medical ICUI Stock Holding History

Caxton Associates (New York)’s Portfolio ICUI Stock Details ICUI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-4,625
Closed -$461K – 516
2023
Q4 		$461K Buy
+4,625
New +$452K 0.02% 338
2022
Q3 		– Sell
-1,758
Closed -$289K – 568
2022
Q2 		$289K Buy
+1,758
New +$338K 0.03% 394
2018
Q4 		– Sell
-2,551
Closed -$721K – 374
2018
Q3 		$721K Buy
2,551
+851
+50% +$249K 0.05% 183
2018
Q2 		$499K Buy
+1,700
New +$465K 0.03% 245
2017
Q3 		– Sell
-2,500
Closed -$431K – 551
2017
Q2 		$431K Buy
+2,500
New +$401K 0.02% 386

Other funds holding ICUI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Caxton Associates (New York)'s ICUI Position: Q1 2024 in Review

Caxton Associates (New York) sold out of ICU Medical (ICUI) in Q1 2024, closing a stake of 4,625 shares — an estimated $461K sold.

Caxton Associates (New York) first reported a position in ICUI in Q2 2017 and held it in 5 quarters. The position peaked at $721K in Q3 2018. 252 funds tracked by Wall St. Rank hold ICUI as of Q1 2024.

  • Caxton Associates (New York) reported no remaining ICU Medical position as of Q1 2024 after selling out during the quarter.
  • Caxton Associates (New York) sold 4,625 ICU Medical shares in Q1 2024, an estimated $461K.
  • Caxton Associates (New York) first reported a position in ICU Medical in Q2 2017 and held it in 5 quarters.
  • Caxton Associates (New York)'s ICU Medical position peaked at $721K in Q3 2018.
  • 252 funds tracked by Wall St. Rank held ICU Medical as of Q1 2024.

Based on Caxton Associates (New York)'s 13F filing for Q1 2024, filed 15 May 2024.